A detailed history of Ever Source Wealth Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,285 shares of CLDX stock, worth $26,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,285
Previous 407 215.72%
Holding current value
$26,432
Previous $13,000 146.15%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$23.31 - $32.4 $20,466 - $28,447
878 Added 215.72%
1,285 $32,000
Q2 2024

Aug 13, 2024

SELL
$32.76 - $42.56 $360 - $468
-11 Reduced 2.63%
407 $15,000
Q1 2024

Jun 11, 2024

BUY
$35.22 - $51.88 $13,348 - $19,662
379 Added 971.79%
418 $17,000
Q4 2023

Feb 09, 2024

BUY
$22.61 - $40.65 $881 - $1,585
39 New
39 $1,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $962M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.